Soma Pharmacy Blognews

Teijin Pharma Launches Febuxostat To Manage Hyperuricemia In Gout Patients
Teijin Pharma has launched TMX-67 (febuxostat) in Europe for the treatment of hyperuricemia in patients with gout.

Sanofi-aventis To Combine Merial With Merck Intervet/Schering-Plough
Sanofi-aventis has exercised its option to combine Merial with Merck’s animal health business Intervet/Schering-Plough to create a global player in animal health. The new joint venture would be equally-owned by Merck and sanofi-aventis.

FDA’s Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF
InterMune, Inc. announced today that the U.S. Food and Drug Administration’s Pulmonary-Allergy drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

Aton Pharma introduces authorized generic version of Timoptic-XE
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE® (timolol maleate ophthalmic gel forming solution). Timoptic-XE is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension [...]

FDA approves BOTOX for treatment of increased muscle stiffness in adults with upper limb spasticity
Allergan, Inc. today announced that the United States Food and Drug Administration has approved BOTOX® (onabotulinumtoxinA) for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity.

Bioniche Pharma introduces Mefoxin in frozen premix bags
Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the launch of Mefoxin® (cefoxitin injection) frozen premix bags. The launch marks the company’s first product offering to be supplied in a frozen premix bag presentation. Mefoxin (cefoxitin injection) is manufactured by Baxter Healthcare Corporation using [...]

NASDAQ halts trading of InterMune’s common stock, FDA PADAC to discuss pirfenidone NDA
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune’s common stock. The Pulmonary-Allergy drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company’s New Drug Application for pirfenidone for the treatment of [...]

Omeros obtains exclusive license to compounds from Asubio Pharma for use in its PDE7 program
Omeros Corporation today announced that it has obtained an exclusive license to compounds from Asubio Pharma Co., Ltd. for use in its PDE7 program, which is focused on the treatment of movement disorders.

Patients taking warfarin who develop acute stroke more likely to experience brain hemorrhage
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a report posted online today that will appear in [...]

WADA, IOC compliant safe alternatives to dangerous and illegal anabolic steroids
SteroidAlternatives.com has launched a cutting-edge line of legal, powerful, and safe alternatives to dangerous and illegal anabolic steroids. All products offered by SteroidAlternatives.com are WADA (World Anti-Doping Agency) and IOC (International Olympic Committee) compliant. This line of products is effective and offers the consumer a [...]